Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07418047 · ClinicalTrials.gov registry record · NA

Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults

A NA study, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
60
Enrollment target

NCT07418047 is a NA study that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07418047, a NA study, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn whether a novel digital avatar (virtual coach) support program can help emerging adults ages 18-29 who present to the emergency department with suicidal thoughts and alcohol misuse (EA-Avatar). The study also aims to learn whether people find the program easy to use and whether daily surveys and the study design are able to be completed by the majority of emerging adult participants. The main questions this study aims to answer are: * Do participants use the digital program and find it helpful? * Is it possible for participants to complete daily surveys for twenty-eight days and follow-up surveys over twelve weeks? * Are there early signs that the program may help lower alcohol use and suicidal thoughts? Researchers will compare participants who receive the new digital avatar program plus supportive text messages to participants who receive a freely available suicide safety planning app to see if there are differences in use, engagement, and early signs of benefit. Participants will: * Receive standard care from the emergency department * Be randomly put into one of two groups (EA-Avatar or a free suicide prevention app) * Depending on their group, use a new avatar-guided digital support program with text message reminders OR use a free suicide safety planning app * Complete surveys at the start of the study and again at four, eight, and twelve weeks * Complete short daily surveys for twenty-eight days

Interventions

  • BEHAVIORAL EA-Avatar
  • BEHAVIORAL Suicide safety planning app

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-05-18
Est. Completion 2026-08-31
Phase NA

What the Registry Record Tells You About NCT07418047

The ClinicalTrials.gov registry entry for NCT07418047 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which EA-Avatar is the first listed.

NCT07418047 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07418047 about?

NCT07418047 is a clinical study titled "Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults". The goal of this clinical trial is to learn whether a novel digital avatar (virtual coach) support program can help emerging adults ages 18-29 who present to the emergency department with suicidal thoughts and alcohol misuse (EA-Avatar). The study also aims to learn whether people find the program e...

What is the current status of trial NCT07418047?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-05-18. Estimated completion is 2026-08-31.

What interventions are being tested in trial NCT07418047?

The interventions under investigation include: EA-Avatar (BEHAVIORAL), Suicide safety planning app (BEHAVIORAL).

Who is sponsoring clinical trial NCT07418047?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.